Lupin presents Phase 3 data for Solosec in female patients with trichomoniasis EP News Bureau Aug 14, 2020 The company plans to submit a supplemental New Drug Application for Solosec to the FDA for the treatment of trichomoniasis later…
Lupin announces results of Phase 3 study of Single-Dose Solosec for treatment of trichomoniasis EP News Bureau May 4, 2020 Primary endpoint successfully achieved in Phase 3 clinical trial of 147 patients Lupin Pharmaceuticals (Lupin) the US-based…
